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Cobamides are a family of enzyme cofactors that include vitamin B12 (cobalamin) and are
produced solely by prokaryotes. Structural variability in the lower axial ligand has been
observed in cobamides produced by diverse organisms. Of the three classes of lower
ligands, the benzimidazoles are uniquely found in cobamides, whereas the purine and
phenolic bases have additional biological functions. Many organisms acquire cobamides
by salvaging and remodeling cobamides or their precursors from the environment. These
processes require free benzimidazoles for incorporation as lower ligands, though the
presence of benzimidazoles in the environment has not been previously investigated. Here,
we report a new puriﬁcation method and bioassay to measure the total free benzimidazole
content of samples from microbial communities and laboratory media components. The
bioassay relies on the “calcoﬂuor-bright” phenotype of a bluB mutant of the model
cobalamin-producing bacterium Sinorhizobium meliloti. The concentrations of individual
benzimidazoles in these samples were measured by liquid chromatography-tandem mass
spectrometry. Several benzimidazoles were detected in subpicomolar to subnanomolar
concentrations in host-associated and environmental samples. In addition, benzimidazoles
were found to be common contaminants of laboratory media components. These results
suggest that benzimidazoles present in the environment and in laboratory media have the
potential to inﬂuence microbial metabolic activities.
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INTRODUCTION
Cobamides are cofactors that function in a variety of metabolic
processes in animals, protists, and prokaryotes. Cobamides belong
to a broader class of molecules called corrinoids that share a com-
mon cobalt-containing corrin ring. Cobamides are corrinoids that
contain a lower axial ligand covalently bound to the corrin ring via
the nucleotide loop (Roth et al., 1996; Escalante-Semerena, 2007).
The essential nutrient cobalamin (Figure 1A, known as vitamin
B12 when taken in its cyanated form as a supplement) is the best
studied cobamide and is well known for its importance in human
health. Cobalamin and other cobamides also function as cofac-
tors for several ecologically important processes in prokaryotes.
For example, cobamides are used as cofactors for methanogene-
sis, acetogenesis, carbon ﬁxation, the formation of toxic methyl
mercury, and the detoxiﬁcation of chlorinated solvents such as
trichloroethene (TCE; Choi et al., 1994; Banerjee and Ragsdale,
2003; He et al., 2007; Ragsdale and Pierce, 2008). Cobamides are
found in host-associated and environmental microbial communi-
ties including the human intestine, bovine rumen, wood-feeding
insects, and TCE-dechlorinating communities (Kräutler et al.,
2003; Allen and Stabler, 2008; Girard et al., 2009; Yi et al., 2012).
The upper (β) ligand of cobamides is the catalytic site (labeled
R in Figure 1A). Adenosylcobamides (R = 5′-deoxyadenosine)
catalyze rearrangement reactions via a radical intermediate, while
methylcobamides (R = CH3) catalyze methyltransfer reactions
(Banerjee and Ragsdale, 2003). The cobamide lower (α) ligand is
the main site of structural diversity, though the biological role for
this diversity is unclear. Lower ligands of cobamides include ben-
zimidazoles such as 5,6-dimethylbenzimidazole (DMB), the lower
ligand of cobalamin (Figure 1); purines; and phenolics (Renz,
1999). Of these classes, the purines and phenolics have other bio-
logical functions,while the benzimidazoles are thought to function
exclusively as cobamide lower ligands.
There is growing evidence that cobamides and their biosyn-
thetic precursors are shared among microbes in complex com-
munities (Seth and Taga, 2014). Bioinformatic analyses indi-
cate that the majority of bacteria that are capable of using
cobamides do not synthesize them de novo, but instead import
cobamides produced by other organisms (Zhang et al., 2009; Deg-
nan et al., 2014). Cobamide biosynthetic intermediates such as
cobinamide (Cbi) and α-ribazole are also taken up and used by
organisms that lack the enzymes for their biosynthesis (Gray
and Escalante-Semerena, 2010; Yi et al., 2012). Additionally,
many prokaryotes including Escherichia coli lack the complete
cobamide biosynthetic pathway but can attach a lower ligand
to a cobamide precursor (corrinoid salvaging), and some, such
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FIGURE 1 | Structure of cobalamin and benzimidazole lower
ligands. (A) Structure of cobalamin. The lower ligand, 5,6
-dimethylbenzimidazole (DMB) is boxed. (B) Structures of lower
ligands used in this study. 5-methylbenzimidazole (5-MeBza),
5-methoxybenzimidazole (5-OMeBza), 5-hydroxybenzimidazole (5-OHBza),
and benzimidazole (Bza).
as Dehalococcoides mccartyi, can remove and replace the lower
ligand to form a different cobamide (cobamide remodeling;
Woodson and Escalante-Semerena, 2004; Escalante-Semerena,
2007; Gray and Escalante-Semerena, 2009; Yi et al., 2012). Some
prokaryotes capable of synthesizing cobamides de novo can also
attach an exogenously provided lower ligand to form a different
cobamide, a process known as guided biosynthesis (Perlman, 1959,
1971). Corrinoid salvaging, cobamide remodeling, and guided
biosynthesis activities require the presence of a free lower lig-
and base such as DMB in the environment (Escalante-Semerena,
2007). Indeed, the availability of DMB may be crucial for the
production of biologically active cobamides by environmental
bacteria such as D. mccartyi (Men et al., 2014b). Interestingly,
although the availability of free lower ligands in microbial
communities has not been investigated previously, DMB has
been reported to be a contaminant of common laboratory agar
(Anderson et al., 2008).
Here, we have developed a new method for the puriﬁca-
tion, detection, and quantiﬁcation of free benzimidazoles that
are commonly found as cobamide lower ligands. We report the
development of a bioassay for the quantiﬁcation of benzimi-
dazoles based on the “calcoﬂuor-bright” (CFB) phenotype of
Sinorhizobium meliloti mutants that lack a functional bluB gene,
which encodes the enzyme responsible for the oxygen-dependent
biosynthesis of DMB (Campbell et al., 2006; Taga et al., 2007).
The CFB phenotype is indicative of an increased abundance or
structural alteration in the exopolysaccharide (EPS) succinogly-
can, and this phenotype has been observed previously in strains
containing mutations in genes involved in amino acid starvation
and the regulation, biosynthesis, and processing of succinoglycan
(Finan et al., 1985; Doherty et al., 1988; Wells and Long, 2002;
Campbell et al., 2006; Gibson et al., 2006; Taga et al., 2007; Pinedo
et al., 2008; Morris and González, 2009). In this work we have
found that the CFB phenotype of the bluB mutant results from
a deﬁciency in the activity of the cobalamin-dependent ribonu-
cleotide reductase (RNR) enzyme and is due to a previously
unrecognized link between theCFBphenotype andDNA stress. By
developing and applying a bioassay based on the CFB phenotype,
we show that benzimidazoles are present in subpicomolar to sub-
nanomolar concentrations in a variety of environmental samples,
as well as in common components of laboratory media.
MATERIALS AND METHODS
BACTERIAL STRAINS AND CULTURE CONDITIONS
All S. meliloti strains are derivatives of the wild type (WT) strain
Rm1021 (Meade et al., 1982). The bluB::gus GmR strain was used
for theCFbioassay (Campbell et al., 2006). S.meliloti cultureswere
grown with aeration at 30◦C in LB medium supplemented with
2.5 mM CaCl2 and 2.5 mM MgSO4 (LBMC), or in M9 minimal
medium with 0.2% sucrose, 10 μg/L biotin, 1 mg/mL methion-
ine, and 10 μM CoCl2 (Maniatis et al., 1982). For growth on solid
media, technical grade agar (Difco) was added at a ﬁnal concentra-
tion of 15 mg/mL. When necessary, antibiotics were added at the
following concentrations (μg/mL): gentamicin, 25; tetracycline,
10; streptomycin, 500; and spectinomycin, 100.
S. meliloti CALCOFLUOR PHENOTYPE ON AGAR PLATES
To assay the CF phenotype on solid media, 100 μL of a liq-
uid culture was spread on LBMC agar containing 0.02% CF and
10 mM HEPES buffer at pH 7.4. Sterile ﬁlter disks were placed
on the agar surface, and the compound being tested was applied
to each disk as indicated. The plates were incubated for 2–3 d
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at 30◦C and then photographed under ultraviolet (UV) light.
10 μL of each tested compound was added, except when indi-
cated, at the following concentrations: nalidixic acid, 50 mM;
mitomycin C, 2 mg/mL (30 μL); cisplatin, 0.8 mg/mL (20 μL);
methyl methanesulfonate (MMS), 1%; 4-Nitroquinoline-1-Oxide
(4NQO), 2 mg/mL (30 μL); gentamicin, 50 mg/mL; neomycin,
200mg/mL; chloramphenicol, 20mg/mL; tetracycline, 0.1mg/mL;
methanol, 95% (20 μL); N-butanol, 99%; cobalt chloride, 1 M;
iron(III) chloride, 1 M; Ethylenediaminetetraacetic acid (EDTA),
0.5 M; ethylene glycol tetraacetic acid (EGTA), 0.5 M; sodium
hydroxide (NaOH), 5 N; formic acid, 80%, Tween, 99%, Tri-
ton X-100, 99%, dimethyl sulfoxide (DMSO), 99%, hydroxyurea,
100 mM; hydrogen peroxide, 10%; menadione, 9 mg/mL; cumene
hydroperoxide, 8%; and sodium dodecyl sulfate (SDS), 10%.
S. meliloti CALCOFLUOR BIOASSAY TO DETECT BENZIMIDAZOLES
Three independent cultures of S. meliloti bluB::gus GmR were
grown in LBMC liquid medium for 40–48 h. The cultures were
diluted in M9 to an O.D.600 of 0.04 in 96-well microtiter plates
and mixed with known concentrations of DMB standards or dilu-
tions of a sample to be tested, in a total volume of 200 μL per
well. All solutions were sterilized by passing through a 0.22 μm
or 10,000 molecular weight cut-off ﬁlter (MWCO, Pall, Port
Washington, New York, USA) prior to use. The edges of the
plates were sealed with paraﬁlm and the plates were placed
on a moist paper towel in a sealed plastic bag to limit evap-
oration. The plates were incubated in a shaking incubator at
30 ◦C for 55–70 h. CF was added to a ﬁnal concentration of
80 μg/mL, bringing the total volume to 300 μL per well, and
the plate was incubated at room temperature in the dark for
an additional 5 h. Fluorescence was measured using a BioTek
Synergy 2 plate reader with excitation at 360 nm and emis-
sion measured at 460 nm. Sigmoidal curves were solved using
the KaleidaGraph program with the equation y = m1 + (m2–
m1)/(1 + (x/m3)ˆm4), where y, m1, m2, m3, m4, and x
correspond to the observed ﬂuorescence at a given dilution fac-
tor, the minimum ﬂuorescence value, the maximum ﬂuorescence
value, the EC50, the slope at EC50, and the dilution factor of
the sample, respectively. The EC50 error was calculated by the
program.
SAMPLE PREPARATION
5-hydroxybenzimidazole (5-OHBza) was synthesized and puri-
ﬁed from 5-methoxybenzimidazole (5-OMeBza) as previously
described (Renz et al., 1993; Crofts et al., 2013). DMB (Sigma–
Aldrich), 5-methylbenzimidazole (5-MeBza, Acros Organics),
5-OMeBza (Sigma–Aldrich), and benzimidazole (Bza, Sigma–
Aldrich) were purchased in powder form and stored at −20◦C
as DMSO stock solutions.
To obtain cell-free supernatants, cultures of WT S. meliloti
Rm1021 and bluB mutant strains containing the plasmids pMS03-
bluB (Yu et al., 2012) or pJL1031 (bluB cloned under its native
promoter in pFAJ1700; Campbell et al., 2006) were grown in M9
liquid medium for 48 h. Samples were diluted in M9 to an O.D.600
of 0.75 and supernatantswere collected by centrifugation at 9,000 g
for 5 min. Sample were passed through a 10,000 MWCO ﬁlter to
remove cells.
Seven and half gram of technical grade agar (Difco), plant cell
culture tested agar (Sigma), noble agar (US Biological), agarose
(Fisher), and yeast extract (Becton Dickinson) were suspended in
300 mL of phosphate buffered saline (PBS) adjusted to pH 8.0.
Rumen ﬂuid from two ﬁstulated cows fed on a high forage diet
(Cows 1921 and 1927, a gift from Ed DePeters, UC Davis Depart-
ment of Animal Science) was collected in September, 2009, and
stored at−20◦C. Thirty-ﬁvemilliliter aliquots of rumen ﬂuidwere
clariﬁed by centrifugation and diluted to 75 mL in PBS adjusted
to pH 8.0.
Ten gram of termite fecal pellets obtained from a laboratory
colony of Zootermopsis sp. was suspended in 75 mL of PBS
and the pH was adjusted to 8.0. Topsoil from the UC Berke-
ley campus Eucalyptus Grove and soil adjacent to Strawberry
Creek on the UC Berkeley campus (GPS coordinates 37.870958,
−122.264433) were collected in September, 2013. Ten gram of
each sample was suspended in 75 mL of PBS and the pH was
adjusted to 8.0. These samples were clariﬁed by passing through
a syringe containing a cotton plug. Water from Strawberry Creek
was collected from an adjacent location. A 6.5 by 45 cm Wino-
gradsky column (a gift from Sydney Kustu) was established over
20 years ago with San Francisco bay mud and maintained in
the lab with natural sunlight and periodically reﬁlled with set-
tled deionized water. Aqueous samples (1 L of creek water or
75 mL of the upper portion of the Winogradsky column) were
mixed with NaCl, KCl, Na2HPO4, and K2HPO4 to adjust the salt
and buffer content to that of PBS, and the pH was subsequently
adjusted to 8.0.
PURIFICATION OF BENZIMIDAZOLES
Samples were mixed with an equal volume of ethyl acetate
(ACS certiﬁed grade) and shaken vigorously in a separatory fun-
nel. The organic layer was removed, and the extraction of the
aqueous layer was repeated with an additional volume of ethyl
acetate. The organic phase from the two extractions were pooled,
and solvent was removed by rotary evaporation at 50◦C. Sam-
ples were resuspended in PBS and applied to a 360 mg C18
Sep-Pak (Waters, Milford, Massachusetts) previously activated
with 3 mL of methanol and equilibrated with 6 mL deionized
water. The cartridge was washed with 6 mL of 30% methanol
and eluted with 2 mL of 70% methanol. The eluate was col-
lected and dried under reduced pressure at 45◦C. The ﬁnal
product was resuspended in deionized water, ﬁltered through
a 10,000 MWCO spin ﬁlter, and stored at −20◦C prior to
analysis.
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) AND
LC/MS/MS ANALYSIS
To determine the efﬁciency of the extraction method, 250 nmol
of DMB, 5-MeBza, 5-OMeBza, 5-OHBza, benzimidazole (Bza),
and cobalamin were extracted as described above. Samples were
analyzed with an Agilent 1200 series high performance liq-
uid chromatography (HPLC) system equipped with a diode
array detector. Samples were analyzed on an Agilent SB-Aq
4.5 × 150 mm column (5 μm pore size) at 1.5 mL/min
at 40◦C with a gradient of 2–100% buffer B over 10 min,
where buffer A was 10 mM ammonium acetate pH 6.5 and
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buffer B was 100% methanol. Quantiﬁcation was achieved by
comparing peak areas at 280 nm with standards of known
concentration. Liquid chromatography-tandem mass spectrom-
etry (LC/MS/MS) was carried out on an Agilent 6410 liquid
chromatograph-triple quadrupole mass spectrometer with mul-
tiple reaction monitoring, using a recently reported quantitative
method (Men et al., 2014b). Brieﬂy, samples were analyzed on
a 3.0 × 50 mm Agilent C18 Eclipse Plus column (1.8 μm pore
size) at 0.5 mL/min at 40◦C with a gradient of 18–21% buffer
B over 3 min and 21% buffer B for 2 min, where buffer A
was 0.1% formic acid in water and buffer B was 0.1% formic
acid in methanol. The following precursor and product ions
were monitored: m/z119.1 and 65 for Bza, m/z 133.1 and 77
for 5-MeBza, m/z 147.1 and 131 for DMB, m/z 149.2 and
79 for 5-OMeBza, and m/z 135.1 and 53 for 5-OHBza. To
convert the concentrations of each benzimidazole into “DMB
equivalents detected by LC/MS/MS,” the amount of each com-
pound detected by LC/MS/MS was adjusted based on the yield
of the extraction method and the EC50 value calculated by
the bluB bioassay, and normalized to the values obtained for
DMB.
RESULTS
THE CALCOFLUOR BRIGHT PHENOTYPE IS A RESPONSE TO DNA
STRESS IN S. meliloti
We previously found that the CFB phenotype of the S. meliloti
bluB mutant can be rescued by the addition of DMB, which is
used to produce cobalamin (Campbell et al., 2006; Taga et al.,
2007). Bioassays, such as the bacterial assay that enabled the
ﬁrst puriﬁcation of cobalamin (Rickes et al., 1948), can pro-
vide inexpensive, high-throughout, and highly sensitive means
to detect molecules of interest (Kelleher and Broin, 1991). To
investigate the possibility that this phenotype could be used
to detect DMB, we ﬁrst used a ﬁlter disk assay to examine
the effect of DMB concentration on the CFB phenotype of a
bluB mutant. This showed that the size and intensity of the
CF-dim zone surrounding the DMB-soaked disks were posi-
tively correlated with the DMB concentration, suggesting that
the CF phenotype could be used for quantiﬁcation of DMB
(Figure 2A).
To determine what other factors could inﬂuence the CF phe-
notype; we next characterized the physiological basis of the CFB
phenotype of the bluB mutant. Our observation that cobalamin
deﬁciency in S. meliloti results in a CFB phenotype suggests that
one or more enzymes that use cobalamin as a cofactor can inﬂu-
ence the amount or structure of succinoglycan. Two of the three
known cobalamin-dependent enzymes in S. meliloti, methionine
synthase and methylmalonyl-CoA mutase, were previously shown
not to signiﬁcantly affect the CF phenotype of S. meliloti and thus
cannot explain the CFB phenotype of the bluB mutant (Campbell
et al., 2006). Therefore, we hypothesized that the CFB phenotype
could be a result of reduced activity of the Class II RNR encoded
by nrdJ, a cobalamin-dependent enzyme that catalyzes the syn-
thesis of deoxyribonucleotides (dNTPs; Cowles and Evans, 1968;
Lawrence and Stubbe, 1998). To test this possibility, we expressed
the E. coli cobalamin-independent (Class I) RNR encoded by nrdA
and nrdB (Carlson et al., 1984) on a plasmid in a bluB mutant
background and found that the strain has a dim phenotype on
CF plates (Figure 2B). To further examine the link between the
CFB phenotype and RNR activity, we used the SmNrdAB+ strain
(nrdJ with the plasmid expressingE. coli nrdAB; Taga andWalker,
2010). The effect of hydroxyurea, a speciﬁc inhibitor of Class
I RNRs (Elford, 1968), was tested by growing SmNrdAB+ on
an agar plate with a hydroxyurea-soaked ﬁlter disk. A zone of
inhibition was formed surrounding the disk, indicating loss of
viability due to inadequate RNR activity (Figure 2C). In addi-
tion, a CFB phenotype is evident in the colonies surrounding the
zone of inhibition (Figure 2D). Together, these results indicate
that the CFB phenotype can be induced by a reduction in RNR
activity, either by direct inactivation by hydroxyurea treatment of
the SmNrdAB+ strain, or by cobalamin depletion such as in the
bluB mutant.
FIGURE 2 |The calcofluor (CF) phenotype of the Sinorhizobium meliloti
bluB mutant is influenced by DMB availability and DNA stress. (A) CF
ﬂuorescence of S. meliloti bluB on an LB CF plate. Filter disks containing
DMB at the indicated concentrations were applied to the plate. (B) CF
ﬂuorescence phenotypes of S. meliloti strains (1) bluB mutant expressing
Escherichia coli nrdAB on plasmid pMS03 ( Taga andWalker, 2010), (2) Wild
type (WT) S. meliloti with empty vector pMS03, (3) bluB mutant with empty
vector pMS03, and (4) bluB mutant expressing E. coli metE on plasmid
pMS03 ( Taga andWalker, 2010). (C) Strain SmNrdAB+ on an LB CF plate
with a ﬁlter disk containing hydroxyurea, photographed under white light.
(D) Same as (C) but photographed under UV light. (E) Fluorescence ofWT S.
meliloti on an LB CF plate with a ﬁlter disk containing nalidixic acid. Filter
disks were applied to the plates at the time of inoculation. (F) Schematic
description of the physiological link between the bluB mutation and the CF
ﬂuorescence phenotype. The dashed line indicates that the mechanism is
unknown.
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Because inactivation of RNR results in a depletion of dNTP
pools and replication fork arrest in E. coli (Guarino et al.,
2007), we hypothesized that the CFB phenotype in the bluB
mutant is a response to DNA stress. To test this possibil-
ity, we exposed WT S. meliloti to nalidixic acid, a DNA
gyrase inhibitor that induces DNA damage (Pommier et al.,
2010), and found that it induced a CFB phenotype adjacent
to the zone of inhibition in the ﬁlter disk assay (Figure 2E).
Treatment with four other DNA damaging agents resulted in
a similar phenotype, suggesting that the CFB phenotype is
induced in response to DNA damage (Table 1). To deter-
mine the range of compounds that induce the CFB pheno-
type, WT S. meliloti and the SmNrdAB+ strain were analyzed
using the ﬁlter disk assay with a variety of toxic agents. Of
the 21 other compounds that induced a zone of inhibition,
only three antibiotics, and SDS induced the CFB phenotype
in WT S. meliloti (Table 1). Three other compounds, all of
which cause intracellular oxidative damage, induced the CFB
phenotype only in SmNrdAB+, consistent with the previously
observed sensitivity of this strain to reactive oxygen species
(Taga and Walker, 2010). These results explain the physiologi-
cal link between bluB and the CFB phenotype, as summarized in
Figure 2F.
CALCOFLUOR FLUORESCENCE PHENOTYPE OF S. meliloti bluB IN
LIQUID MEDIA
The apparent dose-dependent relationship between the concen-
tration of DMB and the CF phenotype on plates (Figure 2A)
suggests that the CF phenotype of the bluB mutant could
be used for the quantitative detection of DMB. To investi-
gate whether the CFB response can be adapted for liquid
media in a 96-well plate format, WT S. meliloti and a bluB
mutant were cultured for 45 h in a 96-well plate, mixed with
CF, and the ﬂuorescence was measured in a multiwell plate
reader. As on solid media, the bluB mutant showed signiﬁ-
cantly higher ﬂuorescence than WT S. meliloti, with a 27-fold
difference in ﬂuorescence between the two strains (Figure 3A).
Culturing the bluB mutant in the presence of DMB or cobal-
amin resulted in a low level of ﬂuorescence comparable to
that of WT S. meliloti, consistent with the phenotype on agar
plates (Figure 3A; Campbell et al., 2006). A greater separa-
tion of the dim and bright phenotypes was observed as the
bacteria were cultured for longer periods prior to the addi-
tion of CF (Figure 3B). Further optimization showed that the
greatest difference in ﬂuorescence was achieved when the cul-
tures were incubated with CF for 5 h (Figure 3C). Based
on these observations, the remaining CF ﬂuorescence mea-
surements were performed by incubating cultures with CF
for 5 h following at least 55 h of growth in the 96-well
plates.
To determine whether the CFB phenotype showed a repro-
ducible, dose-dependent relationship with DMB concentration,
cultures of the S. meliloti bluB mutant were grown with DMB
at concentrations ranging from 0.24 to 250 nM and incu-
bated with CF. The results in Figure 3D show a relation-
ship between ﬂuorescence, and to a lesser extent the ﬁnal
O.D.600 of the cultures, with the concentration of DMB added.
The linear range of the curve was between 4 and 40 nM,
and the concentration of DMB that resulted in half max-
imal ﬂuorescence (EC50) was calculated to be 13 nM. The
average and SD of the EC50 values were 7.37 and 5.59 nM,
respectively, in 26 independent experiments. Replicates per-
formed in a single experiment gave results with lower variation
(Figures 3D and 4A), demonstrating that this method can be
used to detect DMB in unknown samples and quantify DMB
concentrations if DMB standards are measured in the same
experiment.
THE CFB PHENOTYPE OF THE S. meliloti bluB MUTANT IS RESCUED IN
A DOSE-DEPENDENT MANNER BY OTHER COBAMIDE-ASSOCIATED
BENZIMIDAZOLES
We recently reported that an S. meliloti bluB mutant can incor-
porate a variety of benzimidazoles, including all of those in this
study, into cobamides by guided biosynthesis, and that nearly all
Table 1 | Compounds tested for induction of CF bright phenotype in Sinorhizobium meliloti.
Agents that induce a CFB
ring in Rm1021, SmNrdJ+,
and SmNrdAB+
Agents that do not induce
a CFB ring
Agents that induce a CFB
ring only in SmNrdAB+
DNA damaging agents Nalidixic acid, mitomycin C,
cisplatin, MMS, 4NQO
Antibiotics Gentamycin, tetracycline Chloramphenicol,
spectinomycin, kanamycin
Organic compounds Methanol, butanol
Metals and chelators Cobalt, iron, EDTA, EGTA
Acid/base NaOH, formic acid
Agents that cause membrane stress SDS Tween, triton, DMSO
ROS and ROS-generating compounds Hydroxyurea, hydrogen
peroxide, menadione,
cumene hydroperoxide
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FIGURE 3 | Optimization of the S. meliloti bluB CF bioassay to quantify
benzimidazoles. (A) CF ﬂuorescence of liquid cultures ofWT S. meliloti, an
S. meliloti bluB mutant (bluB), or S. meliloti bluB grown in the absence (−) or
presence of 0.5 μM DMB or 1 μM cobalamin. Error bars represent the SE of
three independent experiments. (B) Development of the CFB phenotype as a
function of growth. S. meliloti bluB was grown in the presence and absence
of 0.5 μM DMB. At the indicated time points, aliquots were removed and
incubated with CF for 5 h. The difference in the CF ﬂuorescence of cultures
with and without DMB is plotted. (C) Development of the CFB phenotype as
a function of incubation time with CF. After growth of S. meliloti bluB with
(circles) and without (squares) DMB for 48 h, CF was added and ﬂuorescence
was measured at the indicated time points. Triangles represent the difference
in ﬂuorescence between the two cultures. (D) CF ﬂuorescence (left axis,
circles) and optical density (O.D.600; right axis, triangles) is shown for the S.
meliloti bluB mutant incubated in a 96-well plate with the indicated
concentrations of DMB for 48 h followed by addition of CF for 5 h. Error bars
represent the SE of six independent experiments. Fluorescence is presented
in arbitrary units (FU).
of these cobamides can support growth (Crofts et al., 2013; Hazra
et al., 2013). In contrast, cobamides containing purines or phe-
nolics do not support S. meliloti growth (Crofts et al., 2013). We
therefore reasoned that the bluB bioassay could also be used to
detect benzimidazoles other than DMB, and would not be subject
to interference by cellular metabolites such as adenine. To test this
possibility, the bluB bioassay was used to examine the CF response
to the four other benzimidazoles shown in Figure 1B. All of these
compounds were also able to rescue the ﬂuorescence phenotype of
the bluB mutant in a dose-dependent manner, though their EC50
values were 5- to 45-fold higher than for DMB (Figure 4). The
addition of cobalamin similarly rescued the CFB phenotype, with
an EC50 value 14-fold higher than for DMB (Figure 4F). These
results demonstrate that this CF-based method can be used as a
bioassay for detecting cobalamin and several benzimidazoles.
DETECTION OF BENZIMIDAZOLES IN ENVIRONMENTAL SAMPLES
The bluB bioassay was used to measure the concentrations
of benzimidazoles present in environmental samples. Because
environmental samples may contain compounds such as DNA
damaging agents or cobamides that could interfere with the CFB
response to benzimidazoles, and because the concentrations of
benzimidazoles could be below our detection limit, we ﬁrst devel-
oped a method to purify benzimidazoles from complex mixtures
and concentrate them by up to 3000-fold. This method consists
of a liquid–liquid extraction with ethyl acetate followed by C18
solid phase extraction (see Materials and Methods for details).
The recovery of each benzimidazole varied following this puriﬁ-
cation method, with the highest yield observed for DMB and the
lowest for 5-OHBza; Figure 5). Importantly, cobalamin could not
be detected after this procedure, indicating that the bioassay results
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FIGURE 4 | Calcofluor response of S. meliloti bluB to other
benzimidazoles and cobalamin.The CF ﬂuorescence of cultures grown
with the indicated concentrations of (A) DMB, (B) 5-OHBza, (C) 5-MeBza, (D)
Bza, (E) 5-OMeBza, and (F) cobalamin was assayed as shown in Figure 3D.
The EC50 of each compound and curve-ﬁt error are indicated on each graph.
Error bars represent the SE of three independent experiments.
would not be inﬂuenced by cobalamin (or other corrinoids) that
may have been present prior to puriﬁcation (Figure 5).
To test whether the CF bioassay can quantify benzimidazoles
present in complex mixtures, we performed the puriﬁcation and
bioassay with serial dilutions of spent media from cultures of WT
S. meliloti, the bluB mutant, and two bluB mutant strains contain-
ing plasmids expressing bluB at different levels (Campbell et al.,
2006; Yu et al., 2012). Strains containing the plasmid pMS03-bluB
produce DMB at a high level such that when grown on solid media
adjacent to a bluB mutant, they can induce a CF-dim phenotype in
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FIGURE 5 | Efficiency of extraction of benzimidazoles and cobalamin.
The percent recovery following extraction and puriﬁcation of the indicated
compounds is shown. Bars represent the average of three replicates, and
error bars represent the SE. ND, not detected, limit of detection was
5 pmol.
neighboring colonies (Yu et al., 2012). The plasmid pJL1031 does
not have this ability, suggesting that strains containing this plasmid
produce DMB at lower levels (Campbell et al., 2006). Consistent
with these phenotypes, no DMB was detected in any of the sam-
ples except the strain containing pMS03-bluB. The concentration
of DMB in this sample was found to be 400 nM based on dilu-
tions whose CF ﬂuorescence fell within the linear range of the
DMB standard curve (Table 2). These results indicate that the CF
bioassay can be used to measure DMB in biological samples.
It was previously reported that DMB is a contaminant of
standard laboratory agar and that noble agar has less DMB con-
tamination (Anderson et al., 2008). To measure the concentration
of DMB in laboratory agars, we carried out the benzimidazole
puriﬁcation and CF bioassay on three grades of agar as well as
agarose. Because the bioassay can detect multiple benzimida-
zoles, and because the puriﬁcation yield and CF response to each
benzimidazole varies, the results of the bioassay are reported as
“DMB equivalents” which is calculated based on the extraction
efﬁciency and the ﬂuorescence response for DMB (see Materi-
als and Methods). The bioassay detected benzimidazoles at levels
equivalent to 1-3 pmol of DMB per gram of agar, and the lev-
els did not correlate with the grade of agar (Table 2). We also
measured the benzimidazoles present in commercial yeast extract
by the same method. Surprisingly, the bioassay showed DMB
equivalents 10 times higher than in the agar samples, despite the
fact that yeasts are not known to synthesize benzimidazoles or
cobamides.
The gastrointestinal tracts of several animals have been found
to contain high concentrations of corrinoids. Bovine rumen, ovine
tissue, wood-feeding insects, and the feces of humans, cows,
and pigs have concentrations of corrinoids up to 2 μg per gram
of sample, though the concentrations of free benzimidazoles in
these environments have not been reported (Brown et al., 1955;
Wakayama et al., 1984; Kelly et al., 2006; Allen and Stabler, 2008;
Girard et al., 2009). We detected approximately 300 pM DMB
equivalents in each of two bovine rumen ﬂuid samples, while
in termite fecal pellets ∼0.9 pmol/g was detected (Table 2). Envi-
ronmental samples not associated with an animal host, including
two soil samples and one creek water sample, contained DMB
equivalents similar to termite feces (0.5–0.7 pmol/g and 7 pM,
respectively; Table 2). In addition, approximately 100 pM DMB
equivalents were measured in a laboratory Winogradsky column
(Table 2).
To quantify the individual benzimidazoles present in each sam-
ple, we used a recently developed LC/MS/MS method that can
detect and quantify the ﬁve benzimidazoles shown in Figure 1B
(Men et al., 2014b). This method quantiﬁes molecules based on
speciﬁc retention times and unique fragmentation patterns by
comparison to authentic standards. LC/MS/MS analysis indicated
that nearly all of the samples contained multiple benzimidazoles
in different concentrations. The total concentrations of benzim-
idazoles measured by LC/MS/MS were 2- to 10-fold lower than
those calculated by the bluB bioassay in most cases, suggesting
that additional benzimidazoles not included in our LC/MS/MS
detection method could be present (Table 2). The benzimidazoles
detected in our samples are likely not a result of abiotic degra-
dation of cobamides during the puriﬁcation process because an
analysis of the cobamide content of some of the samples showed
that cobamides corresponding to each benzimidazole were not
present (data not shown). However, other products may lead to
an overestimation of benzimidazole content in the bioassay, as
discussed below. In sum, these results suggest that different com-
binations and concentrations of benzimidazoles are present in a
variety of environments.
DISCUSSION
Cobamides are important cofactors for diverse metabolic pro-
cesses in the majority of prokaryotes as well as in animals and
protists (Roth et al., 1996). Emerging work has shown that both
cobamides and lower ligands are shared among microbes that
reside in complex communities (Yan et al., 2012; Yi et al., 2012;
Degnan et al., 2014; Men et al., 2014b). Guided biosynthesis and
cobamide remodeling, two activities that require a free lower lig-
and base, have been observed in pure bacterial cultures, deﬁned
co-cultures, and communities, when amended with a lower ligand
base (Gray and Escalante-Semerena, 2009; Yan et al., 2012; Yi et al.,
2012; Men et al., 2014a). However, it is not known whether these
activities canoccur in environmental settings because the availabil-
ity of free lower ligand bases has not been examined. Here, we have
investigated the availability of free benzimidazoles in environmen-
tal samples. This work shows for the ﬁrst time both the diversity
and potential ubiquity of benzimidazoles in the environment.
Wewere surprised toﬁnd that benzimidazoles couldbedetected
in all of the samples tested (except most of the S. meliloti super-
natants). The presence of benzimidazoles in the soil samples was
not surprising given the presence of Actinomycetes in soil, several
of which are known to encode cobamidebiosynthesis genes includ-
ing bluB (Rodionov et al., 2003). Similarly, the bovine rumen and
termite gut have high concentrations of cobamides, suggesting
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Table 2 | Benzimidazole levels in environmental samples as determined by the S. meliloti calcofluor bioassay and LC/MS/MS.
Sample DMB equivalents
detected by bioassaya
DMB equivalents detected
by LC/MS/MSb
Benzimidazoles detected by LC/MS/MS
DMB MeBza OMeBza Bza OHBza
Cell free supernatants
Wild type (nM) NDBc
bluB (nM) NDB
pMSO3 (nM) 398 ± 172
pJl1031 (nM) NDB
Laboratory agars
Technical (pmol/g) 2.78 ± 1.16 1.81 0.242 0.286 0.231 2.48 6.67
Noble (pmol/g) 2.48 ± 1.66 0.615 0.307 0.370 0.347 0.974 0.942
Plant cell culture tested (pmol/g) 0.950 ± 0.458 0.0944 NQd 0.196 NQ 1.01 NQ
Agarose (pmol/g) 1.84 ± 1.52 0.931 0.845 0.300 0.339 0.653 NQ
Yeast extract (pmol/g) 26.0 ± 1.21 8.28 6.89 7.42 1.84 4.99 1.10
Host-associated samples
Rumen 1 (pM) 262 ± 76.1 600 490 NDe NQ 1500 ND
Rumen 2 (pM) 367 ± 33.9 654 562 ND ND 1250 ND
Termite (pmol/g) 0.851 ± 0.255 0.240 0.181 0.259 NQ 0.442 ND
Environmental samples
Eucalyptus grove soil (pmol/g) 0.694 ± 0.291 0.0355 NQ ND ND 0.483 ND
Creek bank soil (pmol/g) 0.531 ± 0.361 0.0145 NQ ND NQ 0.197 ND
Creek water (pM) 7.36 ± 3.35 0.357 NQ ND NQ 4.86 ND
Winogradsky column water (pM) 104 ± 35.5 28.1 23.9 24.5 ND 22.6 ND
aThe total benzimidazole content is expressed as “DMB equivalents” because the bioassay does not differentiate DMB from other benzimidazoles. Average and SE
of three independent biological replicates are shown.
bExpected bioassay equivalents, see Section “Materials and Methods” for the calculation method.
cNDB not detectable by bioassay, detection limit of 244 pM.
dNQ not quantiﬁable: less than 50 fmol. Compounds were detectable but too dilute for accurate quantiﬁcation.
eND not detected, compounds were below the detection limit of 20 fmol.
that benzimidazole biosynthesis occurs in these environments
(Wakayama et al., 1984; Girard et al., 2009). The physiological
relevance of the concentrations of benzimidazoles we observed
remains unclear, as the highest levels (>100 pM) are slightly
lower than those required to rescue the CFB phenotype of the
S. meliloti bluB mutant (see Figure 4), and the minimum con-
centrations required for incorporation into cobamides in other
bacteria remain untested.Wepreviously observed that a 1,000-fold
higher concentration of benzimidazoles is required to inhibit the
growth of the cobamide-producing bacterium Sporomusa ovata,
suggesting that the concentrations we observed would not drive
guided biosynthesis in all bacteria (Mok and Taga, 2013). How-
ever, certain organisms that do not produce alternative lower
ligands endogenously may be capable of salvaging benzimidazoles
at these concentrations. Additionally, microenvironments within
planktonic communities or bioﬁlms could contain higher local
concentrations of benzimidazoles that may affect nearby cells.
The diversity of benzimidazoles we observed may be under-
estimated, as our LC/MS/MS method detects only ﬁve of the
six known cobamide-associated benzimidazoles (Renz, 1999),
and other benzimidazoles that have not yet been observed
in cobamides may be biologically relevant. It is possible that
other benzimidazoles are present that were not detected by
LC/MS/MS since the total benzimidazole concentration estimated
by LC/MS/MS was lower than the concentration measured by the
bioassay in the majority of samples. Conversely, the benzimidazole
levels measured in the bioassay may have been overestimated
because compounds other than benzimidazoles that cause a reduc-
tion in CF ﬂuorescence could be present in the samples, or the
bioassay may have collectively detected trace amounts of ben-
zimidazoles that, when measured individually, fell below the
quantiﬁable range of the LC/MS/MS method. Finally, we can-
not formally rule out the possibility that some of the compounds
measured as benzimidazoles by LC/MS/MS could instead be other
compounds present in the samples that have chemical proper-
ties very similar to a benzimidazole being detected, including the
same retention time, m/z (to within ∼0.1 amu), and fragmented
product ion m/z values.
Our detection of DMB (and other benzimidazoles) in labora-
tory agars is consistent with a previous study that reported genetic
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evidence that DMB activity is present in standard laboratory agar
at levels sufﬁcient to promote guided biosynthesis in Salmonella
enterica (Anderson et al., 2008). However, it is unclear why we
detected similar concentrations of benzimidazoles in both techni-
cal and noble agars, though this discrepancy could be explained
by a strong response to Bza and 5-OHBza, which were found at
higher levels in technical agar, in S. enterica. Given that agar is
derived from algae, it is likely that the benzimidazoles present in
agar originate from cobamide-producing bacteria associated with
the algal cells (Croft et al., 2005; Helliwell et al., 2011; Kazamia
et al., 2012).
We were particularly surprised to detect a substantial amount
of benzimidazoles in yeast extract, since fungi are reported not to
synthesize cobamides. The presence of these compounds points
to possible cobamide-independent roles for benzimidazoles. One
example of a naturally occurring benzimidazole that is not associ-
atedwith a cobamide is kealiiquinone, a compound extracted from
a sponge of the Leucetta genus, which indicates that benzimidazole
synthesis is not limited to prokaryotes (Akee et al., 1990; Alamgir
et al., 2007). Other benzimidazoles have been found to have bio-
logical activities not clearly associated with cobamide synthesis,
such as inhibition of bioﬁlm formation (Sambanthamoorthy et al.,
2011). Alternatively, DMB may be formed non-enzymatically
from ﬂavins during the production of yeast extract, though the
production of benzimidazoles other than DMB in this manner
would require additional steps (Maggio-Hall et al., 2003). Bacterial
contamination during industrial preparation is another possible
source of benzimidazoles in yeast extract. Regardless of the source,
these compounds were not previously recognized as components
of laboratory yeast extract, and their presence in bacterial growth
media could inﬂuence cobamide-dependent biological processes.
For example, the presence of benzimidazoles in yeast extract and
agar likely explains why the S. meliloti bluB mutant, but not the
cobU mutant, can grow without cobalamin supplementation in
LB liquid medium and on minimal agar plates. The bluB mutant,
which is unable to synthesize DMB, is apparently partially rescued
by benzimidazoles in the media, while the cobU mutant, which
is unable to activate lower ligand bases for attachment, cannot
use the benzimidazoles available in the media (Campbell et al.,
2006; Crofts et al., 2013). The CFB phenotype of the bluB mutant,
which is utilized in the bioassay described here, therefore indicates
a partial rescue of the DMB auxotrophy by benzimidazoles in the
media.
Here, we also present evidence that the CFB phenotype of the
bluB mutant is the result of DNA stress due to inadequate activity
of the cobalamin-dependent RNR. Although DNA stress was not
previously known to elicit a CFB response, the CFB phenotype has
been observed in response to several other types of stress includ-
ing low nutrient conditions and oxidative stress (Wells and Long,
2002). This response is likely due to the ability of EPSs including
succinoglycan to promote bioﬁlm formation and protect against
toxins including reactive oxygen species produced by the plant host
during nodule invasion (Fujishige et al., 2006; Nogales et al., 2006;
Rinaudi et al., 2006; Soto et al., 2006; Lehman and Long, 2013).
The absence of a mucoid colony phenotype in the bluB mutant
suggests that the CFB phenotype is due, at least in part, to a struc-
tural alteration in succinoglycan, rather than overproduction. We
do not yet know the structure of the altered succinoglycan pro-
duced in response to DNA stress, or the beneﬁt, if any, this altered
EPS provides.
We have used two independent methods, a newly developed
bioassay and an LC/MS/MS method, to detect benzimidazoles in
a variety of environments. The prevalence of these compounds
in both aerobic (such as soil and creek water) and anaerobic
environments (such as rumen) is also interesting from a biochem-
ical perspective because their biosynthetic pathways are unknown,
with the exceptionof the aerobic biosynthesis of DMBwhich is cat-
alyzed by BluB (Campbell et al., 2006; Taga et al., 2007). Because
it can be performed in a high-throughput manner, the bioassay
described here could be used as a tool to screen for benzimidazole
production to aid in the identiﬁcation of yet undiscovered benzim-
idazole biosynthetic genes such as the elusive anaerobic pathway
to DMB (Renz, 1999). The identiﬁcation of benzimidazoles in
diverse environments and their roles in cobamide biosynthesis, sal-
vaging, and remodeling reinforces the importance of identifying
these pathways.
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